A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease

Abstract

Background Kawasaki disease (KD) is the leading cause of childhood acquired heart disease in developed nations and can result in coronary artery aneurysms and death. Clinical and epidemiologic features implicate an infectious cause but specific antigenic targets of the disease are unknown. Peripheral blood plasmablasts are normally highly clonally diverse but the antibodies they encode are approximately 70% antigen-specific 1–2 weeks after infection. Methods We isolated single peripheral blood plasmablasts from children with KD 1–3 weeks after onset and prepared 60 monoclonal antibodies (mAbs). We used the mAbs to identify their target antigens and assessed serologic response among KD patients and controls to specific antigen. Results Thirty-two mAbs from 9 of 11 patients recognize antigen within intracytoplasmic inclusion bodies in ciliated bronchial epithelial cells of fatal cases. Five of these mAbs, from 3 patients with coronary aneurysms, recognize a specific peptide, which blocks binding to inclusion bodies. Sera from 5/8 KD patients day ≥ 8 after illness onset, compared with 0/17 infant controls (P < .01), recognized the KD peptide antigen. Conclusions These results identify a protein epitope targeted by the antibody response to KD and provide a means to elucidate the pathogenesis of this important worldwide pediatric problem.

Immune pathogenesis of COVID-19–related multisystem inflammatory syndrome in children

“…A recent study from South Korea reported no temporal association of human coronavirus infection and incidence of Kawasaki disease at the national level (23). Recent research progress supports a presently unidentified so-called new respiratory RNA virus as the cause of the disease (24).…”

Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children

“…Physicians have noted some clinical similarities between MIS-C and Kawasaki disease (KD), a febrile illness of young childhood involving inflammation of the blood vessels that can result in coronary artery aneurysms. KD is presently of unknown aetiology, although substantial recent progress supports a presently unidentified ubiquitous virus as the cause 6 . Patients with MIS-C may have some of the clinical features of KD, including fever, dilation of conjunctival blood vessels, rash and redness of the oropharynx.…”

Kawasaki disease: pathophysiology and insights from mouse models

“…A peptide recognized by antibodies produced during the acute phase of Kawasaki disease has been identified in 2020 (reF. 52 ). Although the protein epitopes seem similar to hepaciviruses 53 , further studies are required to determine the specific gene sequence from which this peptide emerges.…”